What is your point? You are not comparing against the general population to see if there is a difference.
Also from the study:
> Such a low vaccine efficiency against infection by the Gamma variant was not expected because in vitro studies have shown a similar reduction of neutralization for Beta or Gamma variants by BNT162b2-elicited antibodies (5) and a conserved CD4+ T-cell response against spike proteins from the Beta variant (6).
So, no, this was not "business as usual", in fact the results are so shocking that the investigators wrote:
> Given the surprisingly high attack rate, we hypothesized potential dysfunctions of conservation or administration of vaccines, but the absence of traceable cold-chain interruption and the use of different batches seemed to refute this hypothesis.
So the study so far suggests that the Pfizer vaccines may well have an actual low effectivenes rate against this virus variant.
Small nitpick but French Guiana isn’t its own country, it’s a part of France. That being said their population does seem to trend young when compared to the rest of France or other western countries.
From family experience it seems miners these days tend to be in the old, lifer side. Once you've adapted to the hardship, you mostly keep at it. Can be well paying jobs too, in an area with not a lot of jobs...
Also from the study:
> Such a low vaccine efficiency against infection by the Gamma variant was not expected because in vitro studies have shown a similar reduction of neutralization for Beta or Gamma variants by BNT162b2-elicited antibodies (5) and a conserved CD4+ T-cell response against spike proteins from the Beta variant (6).
So, no, this was not "business as usual", in fact the results are so shocking that the investigators wrote:
> Given the surprisingly high attack rate, we hypothesized potential dysfunctions of conservation or administration of vaccines, but the absence of traceable cold-chain interruption and the use of different batches seemed to refute this hypothesis.
So the study so far suggests that the Pfizer vaccines may well have an actual low effectivenes rate against this virus variant.